Polypid Ltd (PYPD)

May 01, 2025

PolyPid Ltd. (NASDAQ:PYPD) Short Interest Update - Defense World

May 01, 2025

Apr 29, 2025

PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025 - GlobeNewswire

Apr 29, 2025

Apr 29, 2025

PolyPid Q1 2025 Earnings Preview: Surgical Outcomes Biopharma Reports May 14 - Stock Titan

Apr 29, 2025

Apr 23, 2025

Reviewing Baxter International (NYSE:BAX) and PolyPid (NASDAQ:PYPD) - Defense World

Apr 23, 2025

Apr 22, 2025

PolyPid to Participate in The Citizens Life Sciences Conference - GlobeNewswire

Apr 22, 2025

Apr 22, 2025

PolyPid to Reveal Next-Gen Surgical Innovation Pipeline at Elite Citizens Life Sciences Conference - Stock Titan

Apr 22, 2025

Apr 19, 2025

Short Interest in PolyPid Ltd. (NASDAQ:PYPD) Declines By 25.9% - Defense World

Apr 19, 2025

Apr 17, 2025

What is HC Wainwright’s Estimate for PolyPid Q1 Earnings? - Defense World

Apr 17, 2025

Apr 16, 2025

What is HC Wainwright’s Forecast for PolyPid Q1 Earnings? - Defense World

Apr 16, 2025

Apr 15, 2025

H.C. Wainwright maintains Buy on PolyPid stock with $11 target - Investing.com Australia

Apr 15, 2025

Apr 15, 2025

PolyPid’s (PYPD) Buy Rating Reaffirmed at HC Wainwright - Defense World

Apr 15, 2025

Apr 14, 2025

H.C. Wainwright maintains Buy on PolyPid stock with $11 target By Investing.com - Investing.com Canada

Apr 14, 2025

Apr 07, 2025

PolyPid stock touches 52-week low at $2.32 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

PolyPid stock touches 52-week low at $2.32 amid market challenges - Investing.com Australia

Apr 07, 2025

Apr 03, 2025

Surgical Site Infections Clinical and Non-Clinical Studies, - openPR.com

Apr 03, 2025

Mar 24, 2025

Barclays Reaffirms Their Hold Rating on PolyPid (PYPD) - The Globe and Mail

Mar 24, 2025

Mar 23, 2025

Comparing Beta Bionics (NASDAQ:BBNX) and PolyPid (NASDAQ:PYPD) - Defense World

Mar 23, 2025

Mar 11, 2025

PolyPid Completes Enrollment in Phase 3 Trial for Surgical Infection Prevention - TipRanks

Mar 11, 2025

Mar 11, 2025

PolyPid Announces Successful Completion of Enrollment in - GlobeNewswire

Mar 11, 2025

Mar 11, 2025

PolyPid Announces Successful Completion Of Enrollment In Phase 3 Shield II Trial Of D-Plex100 For The Prevention Of Abdominal Colorectal Surgical Site Infections - Marketscreener.com

Mar 11, 2025

Mar 11, 2025

PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections - Yahoo

Mar 11, 2025

Mar 10, 2025

Critical Survey: Nyxoah (NASDAQ:NYXH) vs. PolyPid (NASDAQ:PYPD) - Defense World

Mar 10, 2025

Mar 06, 2025

PolyPid (NASDAQ:PYPD) Stock Price Up 0.7% – Should You Buy? - Defense World

Mar 06, 2025

Mar 03, 2025

PolyPid to Participate in the 37th Annual ROTH Conference - GlobeNewswire

Mar 03, 2025

Mar 03, 2025

PolyPid Fireside Chat at ROTH Conference: What New Surgical Innovations Will Management Reveal? - StockTitan

Mar 03, 2025

Feb 27, 2025

Polypid Ltd to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025 - The Globe and Mail

Feb 27, 2025

Feb 13, 2025

PolyPid Ltd. Earnings Call Highlights Promising Prospects - TipRanks

Feb 13, 2025

Feb 13, 2025

PolyPid Ltd. (NASDAQ:PYPD) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 13, 2025

Feb 12, 2025

PolyPid Ltd. Reports Positive Trial Progress and Financial Outlook - TipRanks

Feb 12, 2025

Feb 12, 2025

PolyPid targets SHIELD II trial completion with top-line results in Q2 2025 - MSN

Feb 12, 2025

Feb 12, 2025

PolyPid Updates: New Board Appointment and SHIELD II Trial Progress - TipRanks

Feb 12, 2025

Feb 12, 2025

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results - The Manila Times

Feb 12, 2025

Feb 12, 2025

PolyPid's Phase 3 Trial Nears Completion: Key Financial Updates Reveal Path to Critical Q2 2025 Results - StockTitan

Feb 12, 2025

Feb 07, 2025

PolyPid (PYPD) to Release Earnings on Wednesday - Defense World

Feb 07, 2025

Jan 31, 2025

Head-To-Head Contrast: PolyPid (NASDAQ:PYPD) versus OraSure Technologies (NASDAQ:OSUR) - Defense World

Jan 31, 2025

Jan 31, 2025

PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire

Jan 31, 2025

Jan 30, 2025

Surgical Outcomes Pioneer PolyPid Takes Center Stage at Major Healthcare Conference - StockTitan

Jan 30, 2025

Jan 30, 2025

PolyPid Ltd. to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - Nasdaq

Jan 30, 2025

Jan 30, 2025

PolyPid (NASDAQ:PYPD) Stock Rating Upgraded by RODMAN&RENSHAW - Defense World

Jan 30, 2025

Jan 29, 2025

PolyPid to Report Fourth Quarter and Full-Year 2024 - GlobeNewswire

Jan 29, 2025

Jan 29, 2025

Major Surgical Innovation Updates Expected: PolyPid Sets Critical Q4 Earnings Date - StockTitan

Jan 29, 2025